- Anatomy Of The National Drug Code
- Just Released - The HDMA EDI ASN Guidance For DSCSA
- The Differences Between The DSCSA, FDA Rules and Guidance
- DSCSA: Special Privileges For The "Big-3" Wholesale Distributors, Part 1
- The 2014 FDA DSCSA Workshop
- Randomization—An Interview with Ken Traub—Part 1: GS1 Serial Number Considerations
- The Aggregation Hoax and PIA
Archive for the ‘Supply Network Blog’ Category
I recently read in Pharmaceutical Commerce online magazine about the apparent resolution of the RxUSA lawsuit that had delayed implementaton of a couple of the pedigree provisions of the Federal PDMA (Prescription Drug Marketing Act). While Pharmaceutical Commerce did its usual great job of providing historical context, I thought it might be an appropriate topic for the RxTrace blog. But before I had time to document the history of the PDMA in my own words, Brian Daleiden beat me to it in the Supply Network Blog. So rather than writing my own version, I gladly refer you to his post. Between the Pharmaceutical Commerce article and Brian’s post, I have nothing more to say right now.
The Supply Network Blog is a fairly new publication of TraceLink, the successor to SupplyScape, my former employer. I look forward to hearing more from their blog in the future so I recently subscribed. Check it out and see what you think.
ROC IT Solutions uses RxTrace to help keep abreast with the industry view(s) on the DQSA legislation and how companies are dealing with meeting the mandates. The views and insights are valuable to our assessment of how our product roadmap reacts to best serve our clients.
RxTrace is informative and well-written. It’s my ‘go to’ source for information on serialization and DSCSA.
Look forward to RxTrace News-helps me to better manage key issues
Government and industry between them have made the issues surrounding traceablity and pedigree of medicines confused and fluid – RxTrace is my first choice when I want to untangle the history of these issues and to understand new developments.
RxTrace offers unique context and focus on our industry.
The knowledge presented in RxTrace, not simply the more common focus of the manufacturing, packaging, and regulatory requirements, but Dirk’s wholesale experience provides him with a complex view on the impacts to the end-to-end supply chain.
Rx Trace is an excellent source of timely industry insight that take complex topics and makes them easier to digest and understand
Easy to understand summary and discussion of complex current topics.
I rely heavily on RxTrace to understand what is changing with the DSCSA, the latest with the FDA and the industry in general.
Been following RxTrace ever since some of the very first postings, and it’s one of my absolutely best sources of serious and thorough analyses, on an otherwise very delicate and complicated topic. Dirk’s writings and articles comes highly recommended, and I’m always looking forward to the next posting. Many thanks from Denmark for sharing your thoughts with us all.
India's Data Integrity Problems lnkd.in/bW9SYiK
2014 Fall Conference Season Preview wp.me/pN6hS-1uG
August 18, 2014 (9:20)
2014 Fall Conference Season PreviewDirk, thanks for the list. I'll be at the GS1 and HDMA events. Thinking about...
Ray Vrabel, PharmD
August 13, 2014 (12:13)
The Case Against RFID In PharmaDirk, While you could start with DEA Schedule II medications (e.g., the mo...
August 12, 2014 (2:42)
The Case Against RFID In PharmaFully agree.... now if we could get the S. Korea regulatory agency to drop RF...
Dirk A. Rodgers
August 12, 2014 (12:39)
The Case Against RFID In PharmaRay, Great point and well said. I agree with you. In that case, RFID tags s...
Ray Vrabel, PharmD
August 12, 2014 (12:03)
The Case Against RFID In PharmaIt may be difficult to justify the use of RFID in the supply chain for all ty...